5-(2-chloro-vinyl)-1H-pyrimidine-2,4-dione | 74131-11-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5-(2-chloro-vinyl)-1H-pyrimidine-2,4-dione
• 英文别名: 5-[(E)-2-chloroethenyl]-2,4(1H,3H)-pyrimidinedione；5-[(E)-2-chloroethenyl]-1H-pyrimidine-2,4-dione
• CAS: 74131-11-6
• 化学式: C₆H₅ClN₂O₂
• 分子量: 172.571
• InChiKey: UEMAMXXEHBCGCL-OWOJBTEDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  58.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-(2-chloro-vinyl)-1H-pyrimidine-2,4-dione 在 硫酸氢铵 、 三氟甲磺酸三甲基硅酯 作用下， 以 二氯甲烷 为溶剂， 反应 1.5h， 生成 1-((3S,4S,5R)-3,4-Bis-benzyloxy-5-benzyloxymethyl-tetrahydro-thiophen-2-yl)-5-((E)-2-chloro-vinyl)-1H-pyrimidine-2,4-dione
  参考文献：
  名称：

  A Facile, Alternative Synthesis of 4‘-Thioarabinonucleosides and Their Biological Activities

  摘要：

  4'-Thioarabinonucleosides, which are potential antiviral agents, were synthesized from D-glucose. 1,4-Anhydro-4-thioarabitol (8), which can be derived from diacetone glucose in nine steps, was subjected to Pummerer rearrangement after protection of the hydroxyl groups to give 1-O-acetyl-4-thioarabinose (II), which was condensed with nucleobases to give 4'-thioarabinonucleosides. The 5-substituted-4'-thioaraU (6a-e) derivatives showed anti-HSV-1 activity (ED50 = 0.43-3.50 mu g/mL). 4'-ThioaraG (6h) and 2,6-diaminopurine 4'-thioarabinonucleoside (4'-thioaraDAP, 6g) showed antiviral activity against several herpes viruses and were particularly potent against human cytomegalovirus (0.010 and 0.022 mu g/mL, respectively).

  DOI：

  10.1021/jm9701536
• 作为产物：
  描述：

  5-甲酰基尿嘧啶 在 哌啶 、 吡啶 、 N-氯代丁二酰亚胺 、 potassium acetate 作用下， 以 水 为溶剂， 反应 2.0h， 生成 5-(2-chloro-vinyl)-1H-pyrimidine-2,4-dione
  参考文献：
  名称：

  尿嘧啶的5-卤代ovinyl衍生物的合成及其向2'-脱氧核糖核苷的转化

  摘要：

  在哌啶存在下用丙二酸处理5-甲酰尿嘧啶，得到（E）-5-（2-羧基乙烯基）尿嘧啶，与适当的N-卤代琥珀酰亚胺反应后，得到（E）-5-（2-溴乙烯基）尿嘧啶。 ，（E）-5-（2-氯乙烯基）尿嘧啶和（E）-5-（2-碘乙烯基）尿嘧啶。最后提到的化合物也是通过氯化碘对5-乙烯基尿嘧啶的作用而获得的。用溴处理5-（1-氯丙炔基）尿嘧啶得到5（2-溴-1-氯乙烯基）尿嘧啶，其与甲醇钠反应得到5-溴乙炔基尿嘧啶。（E）-5-（2-溴乙烯基）-尿嘧啶转化为三甲基甲硅烷基衍生物，与2-脱氧-3,5-二-O-（p（-甲苯甲酰基）-α- D-赤-五呋喃糖酰氯，得到被保护的脱氧核糖核苷的α-和β-异头物。用甲醇钠除去对甲苯甲酰基保护基，得到（E）-5-（2-溴乙烯基）-1-（2-脱氧-α- D-赤型-戊呋喃糖基）尿嘧啶和（E）-5-（2-溴夫酰基）-2'-脱氧尿苷。一系列类似的反应，得到（Ë）-5-（2-碘乙

  DOI：

  10.1039/p19810001665

文献信息

• 2,4-Pyrimidinediamine Compounds and Their Uses
  申请人：Singh Rajinder

  公开号：US20150266828A1

  公开（公告）日：2015-09-24

  The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

  本发明提供了抑制IgE和/或IgG受体信号级联反应的2,4-嘧啶二胺化合物，该级联反应导致化学介质的释放，以及合成这些化合物的中介体和方法，以及在多种情况下使用这些化合物的方法，包括在治疗和预防由脱粒和其他由IgE和/或IgG受体信号级联反应激活引起的化学介质释放所表征、引起或相关的疾病。
• Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
  申请人：——

  公开号：US20020193314A1

  公开（公告）日：2002-12-19

  A desired isomer is selectively prepared by phosphorolyzing and isomerizing an anomer mixture of a 1-phosphorylated saccharide derivative while crystallizing one of the isomers to displace the equilibrium. Furthermore, using the action of a nucleoside phosphorylase, a nucleoside is prepared from the 1-phosphorylated saccharide derivative obtained and a base with improved stereoselectivity and a higher yield. This process is an anomer-selective process for preparing a 1-phosphorylated saccharide derivative and a nucleoside.

  通过磷酸解和异构化1-磷酸化糖衍生物的环式异构体混合物，有选择性地制备所需的异构体，同时通过结晶其中一种异构体以移动平衡。此外，利用核苷酸磷酸化酶的作用，从获得的1-磷酸化糖衍生物和一种改善立体选择性和更高产率的碱基中制备核苷酸。该过程是用于制备1-磷酸化糖衍生物和核苷酸的环式选择性过程。
• Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)uracils
  作者：Kyoichi A. Watanabe、Tsann Long Su、Uri Reichman、Nancy Greenberg、Carlos Lopez、Jack J. Fox

  DOI：10.1021/jm00367a020

  日期：1984.1

  Synthesis of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils containing a vinyl (4a), 2-halovinyl (4b-d), or ethyl substituent at C-5 was achieved. These nucleosides were found to be about a log order less active than 2'-fluoro-5-iodo-ara-C (FIAC) against HSV-1, but they are much less cytotoxic against normal human lymphocytes than FIAC. Nucleosides 4a and 4e showed good activity against HSV-1

  合成了在C-5处含有乙烯基（4a），2-卤代戊基（4b-d）或乙基取代基的1-（2-脱氧-2-氟-β-D-阿拉伯呋喃糖基）尿嘧啶。发现这些核苷对HSV-1的活性比2'-氟-5-碘-ara-C（FIAC）的对数活性低，但与FIAC相比，它们对正常人淋巴细胞的细胞毒性小得多。核苷4a和4e对HSV-1（分别为ED50 = 0.16和0.24 microM）和HSV-2（ED50 = 0.69和0.65 microM）表现出良好的活性，几乎没有细胞毒性（ID50大于100 microM）。
• Cyclopropane derivatives and anti-viral agent containing the same
  申请人：Ajinomoto Co., Inc.

  公开号：US05496824A1

  公开（公告）日：1996-03-05

  The present invention provides a pharmaceutical agent having a high pharmaceutical potency against varicella-zoster viruses and herpes simplex viruses, compositions containing the same, and methods for treating varicella-zoster viruses using the same.

  本发明提供了一种具有高抗水痘-带状疱疹病毒和单纯疱疹病毒药效的药物制剂，含有该药物制剂的组合物，以及使用该药物制剂治疗水痘-带状疱疹病毒的方法。
• Treatment of EBV and KHSV infection and associated abnormal cellular proliferation
  申请人：——

  公开号：US20030176392A1

  公开（公告）日：2003-09-18

  A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.

  提供了一种用于治疗、预防和/或预防寄主，特别是感染了爱泼斯坦-巴尔病毒（EBV）的人类的方法和组合物，包括向寄主施用有效量的5-取代尿嘧啶核苷或其药学上可接受的盐或前药，可选地还包括药学上可接受的稀释剂或赋形剂。